Adicet Bio, Inc. (ACET) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

) has been revised to $54.06 / share. This is a decrease of 13.82% from the prior estimate of $62.73 dated February 21, 2026. The price target is an average of many targets provided by analysts. The ...

The Colombian border city of Cúcuta braces for more turmoil.

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of ...

Pregnant people should not be afraid to take Tylenol, experts say, rebuking unproven claims made by the Trump administration that it can cause autism. At a news briefing Monday, President Donald Trump ...

Truist Financial analyst Asthika Goonewardene reiterated a Buy rating on Adicet Bio today. The company’s shares closed last Friday at $7.21. According to TipRanks.com, Goonewardene is a 1-star analyst ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every ...

The em dash has become the telltale tic of the AI age, a piece of punctuation now viewed with suspicion in college essays. But for Matt Prince, an adjunct professor at Chapman University in Southern ...